Výsledky vyhledávání - "Antineoplastic Agents/administration & dosage/therapeutic use"

Antitumoral Effect of Sunitinib-eluting Beads in the Rabbit VX2 Tumor Model

Autor: Julien Namur, Rafael Duran, Alban Denys, Olivier Dormond, Olivier Jordan, Pierre Bize, Laurent A. Decosterd, Eric Doelker, Katrin Fuchs

Publikováno v: Radiology, Vol. 280, No 2 (2016) pp. 425-435

Purpose To measure plasmatic sunitinib concentration (PSC) and intratumoral sunitinib concentration (ITSC) after transcatheter arterial chemoembolization (TACE) with two different sizes of sunitinib-eluting beads (SEBs) in rabbits with VX2 hepatic al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9493c7c552cb70af890858810d58b5ca
https://pubmed.ncbi.nlm.nih.gov/26919561

Zobrazit plný text záznamu

Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application

Autor: Evangelos C. Alexopoulos, K Nomikos, E Vava, Ioannis D. Bassukas, Georgios Gaitanis

Publikováno v: Journal of the European Academy of Dermatology and Venereology. 23:1427-1431

BACKGROUND/AIM: Theoretical considerations support the combination of cryosurgery and topical imiquimod to treat basal cell carcinomas (BCC). The aim of the present study was to test the feasibility and efficacy of 'cryosurgery during continued imiqu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff883ce1414c3853cf6d310ca1251d0f
https://doi.org/10.1111/j.1468-3083.2009.03224.x

Zobrazit plný text záznamu

Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer?

Autor: Pavlidis, Nicholas

Publikováno v: European journal of cancer

The incidence of cancer during pregnancy is a rare phenomenon and is estimated to occur in 1:1000 pregnancies. This co-existence is likely to rise since the delay of childbearing to the later reproductive age is nowadays more common in families. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1911d5d3a0b19c88cd5e136e171e3e
https://pubmed.ncbi.nlm.nih.gov/21944011

Zobrazit plný text záznamu

Prevention of CNS relapse in diffuse large B-cell lymphoma

Autor: Kridel, Robert, Dietrich, Pierre-Yves

Publikováno v: The Lancet Oncology, Vol. 12, No 13 (2011) pp. 1258-66

CNS relapse occurs in about 5% of patients during the course of diffuse large B-cell lymphoma and entails a dismal prognosis. This consideration has led to the adoption of CNS prophylaxis, although known risk factors do not allow for an accurate pred

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1400::76e1b49655b70043478706cd9ac4ee5a
https://archive-ouverte.unige.ch/unige:43603

Zobrazit plný text záznamu

Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors

Autor: Azim, H. A., Jr., Peccatori, F. A., Pavlidis, N.

The association of cancer and pregnancy is increasingly encountered nowadays in clinical practice. Due to the relative rarity of the situation, it lacks a systematized approach. Different systemic therapies are used in managing cancer with uncertaint

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::907a697a4826ea230c3aea89c6b4dee4
http://olympias.lib.uoi.gr/jspui/handle/123456789/20131

Zobrazit plný text záznamu

Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors

Autor: Azim, H. A., Jr., Pavlidis, N., Peccatori, F. A.

Managing pregnant patients with hematological tumors pose even more conflicts compared to solid tumors. Unlike the majority of solid tumors, hematological malignancies are potentially curable; hence it is important to deliver the best treatment optio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::4956650b0f82461e2da17a12b0dd2899
http://olympias.lib.uoi.gr/jspui/handle/123456789/20120

Zobrazit plný text záznamu

Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98

Autor: Emanuele Zucca, Roger Stupp, Shu Fang Hsu Schmitz, Urs Utiger, Simona Bassi, Rolf A. Stahel, Emmie Okkinga, Pierre-Yves Dietrich, Marc Heizmann, Daniel A. Vorobiof, Michele Ghielmini, Urs Hess, Giovanni Martinelli, Thomas Cerny, Andreas Lohri

Publikováno v: Journal of Clinical Oncology, Vol. 28, No 29 (2010) pp. 4480-4484

Purpose We report the long-term results of a randomized clinical trial comparing induction therapy with once per week for 4 weeks single-agent rituximab alone versus induction followed by 4 cycles of maintenance therapy every 2 months in patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dc9b37c20db53971cb8ad0b8376991b
https://doi.org/10.5167/uzh-53278

Zobrazit plný text záznamu

Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis

Autor: Tzioras, S., Pavlidis, N., Paraskevaidis, E., Ioannidis, J. P.

BACKGROUND: A large number of trials have assessed various chemotherapy regimens for the treatment of advanced cervical cancer, but there is uncertainty about the magnitude of survival benefits. METHODS: We searched (last update January 2006) for tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::c973bf70ebb697384379eee6d2f20018
http://olympias.lib.uoi.gr/jspui/handle/123456789/22097

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání